Accurate Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$476K Buy
8,259
+1,371
+20% +$78.7K 0.05% 364
2026
Q1
$404K Buy
6,888
+541
+9% +$31.5K 0.05% 360
2025
Q4
$355K Buy
6,347
+31
+0.5% +$1.49K 0.05% 367
2025
Q3
$277K Sell
6,316
-512
-7% -$23.9K 0.04% 412
2025
Q2
$331K Buy
6,828
+505
+8% +$24.8K 0.05% 339
2025
Q1
$321K Buy
6,323
+183
+3% +$10.7K 0.06% 268
2024
Q4
$343K Buy
6,140
+1,963
+47% +$110K 0.07% 271
2024
Q3
$220K Buy
+4,177
New +$196K 0.04% 348
2024
Q2
Sell
-5,612
Closed -$275K 330
2024
Q1
$275K Buy
5,612
+216
+4% +$11K 0.08% 227
2023
Q4
$271K Sell
5,396
-3,959
-42% -$208K 0.08% 216
2023
Q3
$536K Sell
9,355
-3,516
-27% -$215K 0.17% 130
2023
Q2
$798K Buy
12,871
+3,354
+35% +$225K 0.25% 88
2023
Q1
$669K Buy
9,517
+3,017
+46% +$213K 0.23% 100
2022
Q4
$466K Sell
6,500
-1,247
-16% -$94K 0.17% 108
2022
Q3
$550K Buy
7,747
+1,354
+21% +$98.2K 0.23% 86
2022
Q2
$485K Sell
6,393
-19,742
-76% -$1.5M 0.26% 79
2022
Q1
$1.91M Buy
26,135
+17,311
+196% +$1.16M 0.86% 21
2021
Q4
$518K Buy
8,824
+358
+4% +$21K 0.42% 62
2021
Q3
$490K Buy
8,466
+1,743
+26% +$115K 0.43% 65
2021
Q2
$449K Buy
+6,723
New +$438K 0.39% 65

Other funds holding BMY

Accurate Wealth Management's BMY Position: Q2 2026 in Review

Accurate Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 20% in Q2 2026, buying an estimated $78.7K and bringing the position to 8,259 shares worth $476K. The position accounts for 0.05% of the portfolio, ranked #364.

Accurate Wealth Management first reported a position in BMY in Q2 2021 and has held it in 20 quarters since. The position peaked at $1.91M in Q1 2022. 879 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Accurate Wealth Management held 8,259 shares of Bristol-Myers Squibb worth $476K as of Q2 2026.
  • Accurate Wealth Management bought 1,371 Bristol-Myers Squibb shares in Q2 2026, an estimated $78.7K.
  • Bristol-Myers Squibb made up 0.05% of Accurate Wealth Management's portfolio in Q2 2026, its #364 holding.
  • Accurate Wealth Management first reported a position in Bristol-Myers Squibb in Q2 2021 and has held it in 20 quarters since.
  • Accurate Wealth Management's Bristol-Myers Squibb position peaked at $1.91M in Q1 2022.
  • 879 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Accurate Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.